Johnson & Johnson
(NYSE) JNJ
Johnson & Johnson Financials at a Glance
Market Cap
$589.48B
Revenue (TTM)
$96.36B
Net Income (TTM)
$21.04B
EPS (TTM)
$8.65
P/E Ratio
28.31
Dividend
$5.24
Beta (Volatility)
0.18 (Low)
Dividend
$5.24
Beta (Volatility)
0.18 (Low)
Price
$254.81
Volume
492,882
Open
$247.69
Price
$254.81
Volume
492,882
Open
$247.69
Previous Close
$254.81
Daily Range
$246.50 - $255.10
52-Week Range
$151.01 - $255.10
Estimated Earnings Date
Jul 15, 2026
Dividend
$5.24
Beta (Volatility)
0.18 (Low)
Price
$254.81
Volume
492,882
Open
$247.69
Previous Close
$254.81
Daily Range
$246.50 - $255.10
52-Week Range
$151.01 - $255.10
Estimated Earnings Date
Jul 15, 2026
JNJ News
JNJ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Johnson & Johnson
Industry
Pharmaceuticals
Sector
Health CareEmployees
140,800
CEO
Joaquin Duato, MBA
Website
www.jnj.comHeadquarters
New Brunswick, NJ 08933, US
JNJ Financials
Key Financial Metrics (TTM)
Gross Margin
69.12%
Operating Margin
26.87%
Net Income Margin
21.83%
Return on Equity
26.26%
Return on Capital
19.77%
Return on Assets
10.47%
Earnings Yield
3.53%
Dividend Yield
2.14%
Payout Ratio
59.52%
Stock Overview
Market Cap
$589.48B
Shares Outstanding
2.41B
Volume
492.88K
Avg. Volume
7.90M
Financials (TTM)
Gross Profit
$66.60B
Operating Income
$25.89B
EBITDA
$33.49B
Operating Cash Flow
$22.87B
Capital Expenditure
-$5.07B
Free Cash Flow
$17.80B
Cash & ST Invst.
$22.05B
Total Debt
$54.99B
Johnson & Johnson Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.06B
+9.9%
Gross Profit
$17.20B
+18.3%
Gross Margin
71.49%
N/A
Market Cap
$589.48B
N/A
Market Cap/Employee
$4.16M
N/A
Employees
141,700
N/A
Net Income
$5.24B
-52.4%
EBITDA
$8.27B
-47.0%
Quarterly Fundamentals
Total Cash
$22.05B
-43.1%
Total Debt
$54.99B
+5.2%
Accounts Receivable
$17.72B
+10.6%
Inventory
$14.58B
+15.2%
Long Term Debt
$37.53B
-2.2%
Short Term Debt
$17.46B
+25.6%
Return on Assets
10.47%
N/A
Return on Invested Capital
18.08%
N/A
Free Cash Flow
$1.47B
-56.6%
Operating Cash Flow
$2.51B
-39.8%